| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |